The Centers for Medicare & Medicaid Services (CMS) announced on June 10 new guidance aimed at strengthening patient protections and accountability within the organ donation system. The updated policies clarify the responsibilities of Organ Procurement Organizations (OPOs) and donor hospitals, emphasizing that patients must receive full medical care regardless of their potential donor status and that families should be allowed time to make decisions about organ donation without coercion.
According to CMS Administrator Dr. Mehmet Oz, "Americans’ trust in physicians and hospitals decreased more than 40% between 2020 and 2024. In this administration, we’re committed to earning it back. These guidelines contribute to that effort by directing hospitals to give every patient the same life-saving care, regardless of organ donor status, and to avoid rushing or coercing families into organ donation decisions. We’re restoring trust by promoting transparency, strengthening accountability, and respecting the dignity of patients and their families."
The new guidance is delivered through a Quality, Safety, & Oversight memo and an update to the State Operations Manual appendix. Key points include requiring hospitals to provide complete medical treatment before considering organ donation; ensuring families have adequate time before making decisions; prohibiting OPOs from influencing critical end-of-life decisions; upholding accepted medical standards for death declarations; and protecting against rushed or pressured decision-making.
CMS will require surveyors to cite noncompliance with these federal requirements as soon as they are identified—even if subsequently corrected—marking a significant change intended to increase accountability throughout the system. This move reinforces existing regulations while enhancing oversight.
More than 100,000 Americans are currently waiting for lifesaving organ transplants. The latest action is part of broader efforts by CMS and the Health Resources and Services Administration (HRSA) to modernize oversight of OPOs, improve transparency, ensure public accountability, and advance patient protections across the national organ procurement network.
Further steps outlined by CMS include highlighting national priorities at its 2026 Quality Conference in March 2026; publishing performance reports based on recent data in spring 2026; completing onsite recertification surveys in summer 2026; issuing a final rule on OPO Conditions for Coverage later that year; initiating recertification or decertification actions following implementation; and managing agreement expirations in January 2027 as needed for continuity according to the official roster page.
